Pms-Sugammadex 100 mg (Sugammadex (Sugammadex Sodium) SOLUTION) 100 MG

PMS-SUGAMMADEX 100 MG is an intravenous solution containing Sugammadex Sodium, used for reversing neuromuscular blockade. This medication is manufactured by Pharmascience Inc. in Canada.

Strength

100 MG

Manufacturer / TM Owner

PHARMASCIENCE INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

PMS-SUGAMMADEX 100 MG is primarily used to reverse the effects of neuromuscular blocking agents used during surgical procedures. It helps to restore normal muscle function after anesthesia. This medication is often administered in clinical settings to facilitate recovery from muscle relaxation induced by certain drugs.

Side Effects

Common effects of PMS-SUGAMMADEX 100 MG may include a rapid reversal of muscle relaxation, allowing patients to regain normal muscle function quickly. Some individuals might experience mild side effects, but these are generally well-tolerated.

Precautions & Warnings

PMS-SUGAMMADEX 100 MG should be administered by healthcare professionals in a controlled medical environment. It is important to follow the prescribed guidelines and monitor patients closely for any adverse reactions. Always inform your healthcare provider about any allergies or medical conditions before use.

Avoid Interactions

PMS-SUGAMMADEX 100 MG may interact with other medications, particularly neuromuscular blocking agents. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and certain supplements might also affect the efficacy of this medication.

Frequently Asked Questions

PMS-SUGAMMADEX 100 MG is used to reverse the effects of neuromuscular blocking agents during surgical procedures.

PMS-SUGAMMADEX 100 MG is administered intravenously by healthcare professionals in a clinical setting.

Common effects include a rapid reversal of muscle relaxation, allowing patients to regain normal muscle function quickly.

Yes, it should be administered by healthcare professionals, and patients should be monitored for any adverse reactions.

Yes, it may interact with neuromuscular blocking agents and other medications, so it's important to discuss all current medications with your healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.